Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma.

Shiyu ZengGuolin TanTiansheng WangXianyao WangZheng ZhouJian XiaoTieqi LiGehou ZhangWei Li

Published in: Journal of oncology (2022)

In all, S100A9 plays a crucial role in cisplatin-resistance, proliferation, and migration of HPC. Targeting S100A9 may become a novel strategy for the treatment of HPC.

Keyphrases

cell proliferation
signaling pathway
cancer therapy
combination therapy
smoking cessation